Showing results (431-440 of 658) with videos related to

Sort By:
Pageof 66
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Cancer Medicine|March 7, 2025
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient PopulationBennett A McIver, Tara S Davis, Kimberly Reinhart, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 13, 2012
Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantationGa-Yeong Shin, Jin-Kyoung Shim, Ji-Hyun Lee, et al.
Journal of Neuro-Oncology|May 21, 2026
CSF ctDNA analysis guides molecular reclassification of diffuse glioma patientsSrividya Arjuna, Maryam Pirhoushiaran, Angel Bueno, et al.
Journal of Neuro-Oncology|July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade gliomaTobias Walbert, Mark R Gilbert, Morris D Groves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2Yang Liu, Fu-Ju Chou, Fengchao Lang, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
American Journal of Cancer Research|March 8, 2024
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Neuro-Oncology Practice|July 15, 2026
Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participantsKimberly R Robins, Hope Miller, Michelle L Cassidy, et al.
Pageof 66